SP Angel is delighted to announce it acted as nominated adviser and broker to CRISM Therapeutics on its admission to trading on AIM on 31 May 2024, following the acquisition of Extruded Pharmaceuticals Limited by Amur Minerals Corporation.
SP Angel’s Post
More Relevant Posts
-
DOTA PEG https://lnkd.in/gj4QuzGX DOTA PEG linkers are an important class of molecules widely used in pharmaceutical research and development. These linkers are composed of a DOTA chelator and a polyethylene glycol (PEG) chain. The DOTA moiety is used to bind to metal ions such as copper, gallium or lutetium, while the PEG chain provides stability and solubility to the resulting conjugate.
-
-
Technically, $ATNM price is consolidating effectively around $8.00, demonstrating strength as indicated by positive signals from the MACD and RSI. Recent developments may serve as a catalyst to propel the price upward. Keep an eye on movements above $8.15. #premarket #stockmarket #investing #trading Actinium Pharmaceuticals, Inc.
-
-
How might the biopharma sector fare for the rest of the year? Here's a simple model based on daily data from 2020 to present drawn from the iShares US Pharmaceuticals ETF. The solid blue line is the base projection with the shaded sections showing more positive or negative scenarios. The black lines are actual closing price data.
-
-
Check out our Weekly Watchlist for an update on key catalysts remaining for the quarter! #fasterscience #betherewhenithappens #catalysts #biotech #pharma #biotechinvesting
BioPharmCatalyst Weekly Watchlist for March 16, 2024 Akebia Therapeutics (AKBA) TRACON Pharmaceuticals (TKON) Harmony Biosciences (HRMY) Crinetics Pharmaceuticals (CRNX) Read the full article below to find out why these tickers are key catalysts remaining for this quarter. Subscribe to receive this directly to your inbox each week. https://lnkd.in/eBQ_FgEX #weeklywatchlist #biotechinvesting #biotech2024 #catalysts #betherewhenithappens #fasterscience
-
-
The global biologics market was valued at US$ 294.4 Bn at the end of 2022 and is expected to reach at a value of US$ 529.3 Bn by 2030 with a significant CAGR of 7.6%. 𝐑𝐞𝐚𝐝 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 - https://lnkd.in/gC7fYJM6 #BiologicsMarket
-
Physician, Telemedicine, Author, Hormone and Peptide Therapy, Precision Cellular Medicine and Health and Performance Optimization
The Dangers of statins and modern pharmaceuticals! The beneficial effects of Estradiol and Testosterone on lipids - massively different than the synthetic drugs of modern pharmaceuticals!! https://lnkd.in/eASGfiSg
-
Ph.D. Research Scholar, IIT BHU, Department of Pharmaceutical Engineering and Technology
I'm happy to share my first review article titled as "Liraglutide innovations: a comprehensive review of patents (2014–2024)" in the journal of Pharmaceutical Patent Analyst, Taylor and Francis. Special thanks to my supervisor Prof.Amit Kumar Goyal. In this article I've mentioned all the patents published related to Glucagon-like peptide-1 agonist "liraglutide". Read the full article here: https://lnkd.in/dXppUsUx
-